Robert W. Baird has recently initiated Lexeo Therapeutics Inc (LXEO) stock to Outperform rating, as announced on June 13, 2024, according to Finviz. Earlier, on June 6, 2024, H.C. Wainwright had ...

PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...

Begin your TipRanks Premium journey today. PTC Therapeutics (PTCT) Company Description: PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of ...

The approval marks the first time gene therapy will be available to treat patients with aromatic I-amino acid decarboxylase ...

Q3 2024 Earnings Call Transcript November 13, 2024 Mersana Therapeutics, Inc. misses on earnings expectations. Reported EPS ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Thank you for standing by. My name is Bella, and I will be your ...

CLEVELAND (AP) — CLEVELAND (AP) — Abeona Therapeutics Inc. (ABEO) on Thursday reported a loss of $20.3 million in its third quarter. On a per-share basis, the Cleveland-based company said it had a ...

Bicara Therapeutics Inc. ( (BCAX) ) has released its Q3 earnings. Here is a breakdown of the information Bicara Therapeutics Inc. presented to ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

On Tuesday, Tango Therapeutics Inc (TNGX) stock saw a decline, ending the day at $3.35 which represents a decrease of $-0.03 or -0.89% from the prior close of $3.38. The stock opened at $3.48 and ...

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...